The findings presented in this article open up new fields of research, suggesting the use of this technique for the early diagnosis of ovarian cancer, where transvaginal ultrasound and the CA125 marker have not demonstrated the correct sensitivity and specificity to be used for population screening. This evidence concerns the gene MUC16 and ovarian carcinoma.